Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Plewes, Katherine ^a,b,c   Haider, Md Shafiul ^d   Kingston, Hugh W F ^a,e   Yeo, Tsin W ^e   Ghose, Aniruddha ^d   Hossain, Md Amir ^d   Dondorp, Arjen M ^a,b   Turner, Gareth D H ^a,b   Anstey, Nicholas M ^e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d CHITTAGONG MEDICAL COLLEGE HOSPITAL   (Bangladesh)

^e MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Acute kidney injury; Delayed haemolysis; Falciparum malaria

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; HEMOGLOBIN; ARTEMISININ DERIVATIVE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BANGLADESHI; BLOOD TRANSFUSION; CASE REPORT; DISEASE SEVERITY; EDEMA; FOLLOW UP; HAEM PIGMENT NEPHROPATHY; HEMODIALYSIS; HEMOLYSIS; HEMOLYTIC ANEMIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HYPERPARASITEMIA; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TUBULE DAMAGE; MALARIA FALCIPARUM; MALE; MIDDLE AGED; PARASITEMIA; POST ARTESUNATE DELAYED HEMOLYSIS; ACUTE KIDNEY INJURY; ANEMIA, HEMOLYTIC; BANGLADESH; COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; MALARIA, FALCIPARUM; PARASITOLOGY; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; ADMINISTRATION, INTRAVENOUS; ANEMIA, HEMOLYTIC; ARTEMISININS; BANGLADESH; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PARASITEMIA; TREATMENT OUTCOME;

EID: 84934949362     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0760-x     Document Type: Article

References (39)

1. Camacho LH, Gordeuk VR, Wilairatana P, Pootrakul P, Brittenham GM, Looareesuwan S (1998) The course of anaemia after the treatment of acute, falciparum malaria. Ann Trop Med Parasitol 92:525-537
2. Adner MM, Altstatt LB, Conrad ME (1968) Coombs'-positive hemolytic disease in malaria. Ann Intern Med 68:33-38
3. Omodeo-Sale F, Motti A, Dondorp A, White NJ, Taramelli D (2005) Destabilisation and subsequent lysis of human erythrocytes induced by Plasmodium falciparum haem products. Eur J Haematol 74:324-332
4. Woodruff AW, Ansdell VE, Pettitt LE (1979) Cause of anaemia in malaria. Lancet 1:1055-1057
5. Jaureguiberry S, Ndour PA, Roussel C, Ader F, Safeukui I, Nguyen M et al (2014) Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins. Blood 124:167-175
6. Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, Bierman WF, Clerinx J, van Veldhuizen CK et al (2012) Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J 11:102
7. Experts Group Meeting on delayed anaemia following treatment with injectable artesunate, Wien Austria. (http://www.mmv.org/sites/default/files/uploads/docs/events/2013/InjectableArtesunateExpertGroupMeeting.pdf)
8. Paczkowski MM, Landman KL, Arguin PM (2014) Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria - United States, 2008 and 2013. MMWR Morb Mortal Wkly Rep 63:753-755
9. Rolling T, Agbenyega T, Issifou S, Adegnika AA, Sylverken J, Spahlinger D et al (2014) Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria - a double-center prospective study. J Infect Dis 209:1921-1928
10. Rolling T, Wichmann D, Schmiedel S, Burchard GD, Kluge S, Cramer JP (2013) Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis. Malar J 12:241
11. Zoller T, Junghanss T, Kapaun A, Gjorup I, Richter J, Hugo-Persson M et al (2011) Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis 17:771-777
12. Blum S, Gattringer R, Haschke E, Walochnik J, Tschurtschenthaler G, Lang F et al (2011) The case: hemolysis and acute renal failure. Babesiosis. Kidney Int 80:681-683
13. Clark DA, Butler SA, Braren V, Hartmann RC, Jenkins DE Jr (1981) The kidneys in paroxysmal nocturnal hemoglobinuria. Blood 57:83-89
14. Tran TH, Day NP, Ly VC, Nguyen TH, Pham PL, Nguyen HP et al (1996) Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases. Clin Infect Dis 23:1274-1281
15. Tsai CW, Wu VC, Lin WC, Huang JW, Wu MS (2007) Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria. Kidney Int 71:1187
16. Bunn HF, Jandl JH (1969) The renal handling of hemoglobin. II. Catabolism. J Exp Med 129:925-934
17. Billings FT, Ball SK, Roberts LJ, Pretorius M (2011) Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med 50:1480-1487
18. Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ, Altintas S, Heijmans JH, Koeppel TA et al (2010) Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int 77:913-920
19. Raffray L, Receveur MC, Beguet M, Lauroua P, Pistone T, Malvy D (2014) Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report. Malar J 13:398
20. Rehman K, Lotsch F, Kremsner PG, Ramharter M (2014) Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence. Int J Infect Dis 29:268-273
21. Caramello P, Balbiano R, De Blasi T, Chiriotto M, Deagostini M, Calleri G (2012) Severe malaria, artesunate and haemolysis. J Antimicrob Chemother 67:2053-2054
22. Corpolongo A, De Nardo P, Ghirga P, Gentilotti E, Bellagamba R, Tommasi C et al (2012) Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine. Malar J 11:91
23. De Nardo P, Oliva A, Giancola ML, Ghirga P, Mencarini P, Bibas M et al (2013) Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria. Infection 41:863-865
24. Eder M, Farne H, Cargill T, Abbara A, Davidson RN (2012) Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre. Pathog Glob Health 106:181-187
25. Jarvis JN, Coltart CE, Pule M, Chiodini PL, Doherty T (2013) Artemisinin therapy and severe delayed haemolysis. Lancet 382:180
26. Kano S (2010) Artemisinin-based combination therapies and their introduction in Japan. J Infect Chemother 16:375-382
27. Angus BJ, Chotivanich K, Udomsangpetch R, White NJ (1997) In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood 90:2037-2040
28. Chotivanich K, Udomsangpetch R, Dondorp A, Williams T, Angus B, Simpson JA et al (2000) The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. J Infect Dis 182:629-633
29. Newton PN, Chotivanich K, Chierakul W, Ruangveerayuth R, Teerapong P, Silamut K et al (2001) A comparison of the in vivo kinetics of Plasmodium falciparum ring-infected erythrocyte surface antigen-positive and -negative erythrocytes. Blood 98:450-457
30. Centers for Disease Control and Prevention (CDC) (2013) Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria - worldwide, 2010-2012. MMWR Morb Mortal Wkly Rep 62:5-8
31. Rubin H (1971) Paroxysmal nocturnal hemoglobinuria with renal failure. JAMA 215:433-436
32. Heyman SN, Rosen S, Fuchs S, Epstein FH, Brezis M (1996) Myoglobinuric acute renal failure in the rat: a role for medullary hypoperfusion, hypoxia, and tubular obstruction. J Am Soc Nephrol 7:1066-1074
33. Moore KP, Holt SG, Patel RP, Svistunenko DA, Zackert W, Goodier D et al (1998) A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem 273:31731-31737
34. Yeo TW, Lampah DA, Tjitra E, Gitawati R, Kenangalem E, Piera K et al (2009) Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria. J Infect Dis 200:1522-1529
35. Berkowitz FE (1991) Hemolysis and infection: categories and mechanisms of their interrelationship. Rev Infect Dis 13:1151-1162
36. Boutaud O, Moore KP, Reeder BJ, Harry D, Howie AJ, Wang S et al (2010) Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure. Proc Natl Acad Sci USA 107:2699-2704
37. Janz DR, Bastarache JA, Peterson JF, Sills G, Wickersham N, May AK et al (2013) Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study. Crit Care Med 41:784-790
38. Baek JH, D'Agnillo F, Vallelian F, Pereira CP, Williams MC, Jia Y et al (2012) Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J Clin Invest 122:1444-1458
39. Shibasaki T, Matsuda H, Furuya K (2007) Haptoglobin therapy during pregnancy for paroxysmal nocturnal hemoglobinuria with renal failure. Int J Gynaecol Obstet 98:267-268